Scarica l'app Stockscreener
68.00
0.49%
0.33
Dopo l'orario di chiusura:
69.05
1.05
+1.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$67.67
Aprire:
$67.54
Volume 24 ore:
1.97M
Relative Volume:
1.13
Capitalizzazione di mercato:
$3.61B
Reddito:
-
Utile/perdita netta:
$-38.99M
Rapporto P/E:
-22.69
EPS:
-2.9966
Flusso di cassa netto:
$-24.94M
1 W Prestazione:
+3.72%
1M Prestazione:
+36.79%
6M Prestazione:
-2.76%
1 anno Prestazione:
+24.77%
Intervallo 1D:
$65.39
$72.88
Intervallo di 1 settimana:
$62.93
$72.88
Portata 52W:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Nome
Soleno Therapeutics Inc
Settore
Industria
Telefono
650-213-8444
Indirizzo
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Confronta SLNO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
68.00 | 3.38B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Iniziato | Goldman | Buy |
| 2025-08-20 | Iniziato | Wells Fargo | Overweight |
| 2025-06-23 | Iniziato | TD Cowen | Buy |
| 2025-03-05 | Ripresa | Stifel | Buy |
| 2024-12-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-12-02 | Reiterato | Stifel | Buy |
| 2024-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-05 | Iniziato | Piper Sandler | Overweight |
| 2024-01-23 | Iniziato | Stifel | Buy |
| 2023-11-21 | Ripresa | Guggenheim | Buy |
| 2020-09-29 | Iniziato | Guggenheim | Buy |
| 2020-01-10 | Iniziato | Craig Hallum | Buy |
| 2019-12-23 | Iniziato | Oppenheimer | Outperform |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
Mostra tutto
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Strategies to average down on Soleno Therapeutics Inc.Gold Moves & Short-Term Swing Trade Alerts - newser.com
Soleno Therapeutics gains amind renewed takeover speculation (SLNO:NASDAQ) - Seeking Alpha
Soleno pledges $5M in research funding to look for PWS cure - Prader-Willi Syndrome News
Is Soleno Therapeutics Inc. stock entering bullish territory2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Has Soleno Therapeutics Inc. formed a bullish divergenceQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
How to escape a deep drawdown in Soleno Therapeutics Inc.Weekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com
Will Soleno Therapeutics Inc. outperform the marketIPO Watch & High Return Stock Watch Alerts - newser.com
Is Soleno Therapeutics Inc. building a consolidation baseGold Moves & Technical Pattern Recognition Alerts - newser.com
Soleno Therapeutics Appoints Mark W. Hahn to Board and Audit Committee - TradingView
How to recover losses in Soleno Therapeutics Inc. stockJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
Soleno Therapeutics appoints biopharma finance veteran to board By Investing.com - Investing.com Canada
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action InvestigationSLNO - Eastern Progress
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - WV News
Using Bollinger Bands to evaluate Soleno Therapeutics Inc.2025 Top Gainers & Safe Entry Momentum Tips - newser.com
Multi asset correlation models including Soleno Therapeutics Inc.July 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Soleno Therapeutics appoints biopharma finance veteran to board - Investing.com India
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors - GlobeNewswire
Soleno Therapeutics, Inc. Appoints Mark W. Hahn as an Independent Director to Its Board of Directors and A Member of Its Audit Committee - MarketScreener
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 86% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire
Soleno drops on death of patient treated with Vykat XR - MSN
Soleno Therapeutics stock dips on proposed $200M offering - MSN
Soleno Therapeutics (SLNO): Valuation in Focus After Scorpion Capital Report and Legal Probes on VYKAT XR - Sahm
Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO) - Seeking Alpha
Soleno Therapeutics (NASDAQ:SLNO) Coverage Initiated by Analysts at The Goldman Sachs Group - MarketBeat
How to use Fibonacci retracement on Soleno Therapeutics Inc.Gap Down & Fast Moving Stock Watchlists - newser.com
Published on: 2025-10-10 05:36:53 - newser.com
Can Soleno Therapeutics Inc. stock deliver sustainable ROEMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Published on: 2025-10-09 06:36:22 - newser.com
Will Soleno Therapeutics Inc. bounce back from current supportJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What Wall Street predicts for Soleno Therapeutics Inc. stock priceAnalyst Downgrade & Weekly High Return Stock Forecasts - newser.com
Soleno Therapeutics (NASDAQ:SLNO) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Is Soleno Therapeutics Inc 6XC a good long term investment - earlytimes.in
Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT - Yahoo Finance
Soleno Therapeutics (NASDAQ:SLNO) Trading Up 7%Should You Buy? - MarketBeat
Soleno Therapeutics (SLNO): Reassessing Valuation After VYKAT XR Safety Debate and Analyst Support - Yahoo Finance
Goldman Sachs Initiates Soleno Therapeutics at Buy With $125 Price Target - MarketScreener
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock - GlobeNewswire
Goldman Sachs initiates Soleno Therapeutics stock with Buy rating on Vykat potential - Investing.com
Is Soleno Therapeutics Inc. stock supported by strong cash flows - newser.com
Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Soleno Therapeutics Inc Azioni (SLNO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hirano Patricia C | SEE REMARKS |
Jul 01 '25 |
Sale |
82.76 |
3,830 |
316,971 |
13,206 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):